RecruitingOBSERVATIONAL

Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008

This study is gathering information from patient records across 18 cancer centres in France. It's called "Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008." The main goal is to understand how treatments for metastatic breast cancer have developed and improved over time, starting from 2008. Researchers are looking at existing details like who the patients were, the type of cancer they had, the treatments they received (such as chemotherapy, hormone therapy, and targeted therapies), and how they responded. This helps doctors learn more about the illness and potentially find better ways to care for people in the future.

At a glance

Status

Recruiting

Sponsor

UNICANCER

Enrolment target

42,000

Start

01 Jul 2014

Estimated completion

01 Dec 2027

Metastatic Breast Cancer

What is this study about?

This study, called "Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008," is a look back in time at how metastatic breast cancer has been treated in France since 2008. It's like gathering pieces of a puzzle from the past to understand the bigger picture of how care has changed and what has been effective.

Researchers are collecting information from existing medical records of patients who received treatment at 18 different cancer centres in France. They're looking at various details, including the patient's age and background, the specific characteristics of their breast cancer, the different types of treatments they received (like chemotherapy, hormone therapy, targeted therapy, and radiotherapy), and how their cancer responded to these treatments.

The main aim of this study is to learn from the experiences of many patients. By carefully looking at this information, doctors hope to gain a better understanding of how treatments for metastatic breast cancer have evolved over the years. This knowledge can help improve future care and guide decisions about the best ways to treat people with this condition.

Key takeaways

This study helps doctors learn more about treating metastatic breast cancer.
It uses existing, anonymised patient records from French cancer centres.
No new treatments or appointments are involved for patients.
The information helps understand how care has changed since 2008.
Your privacy is protected, and records are made anonymous.
The findings could lead to better care for future patients.

Who may be eligible?

To be included in this study, patients need to be at least 18 years old. They must have received treatment for their metastatic breast cancer at one of the participating French cancer centres since January 2008.

This study specifically looks at records of patients who were treated for their first instance of metastatic breast cancer at these centres. Treatments considered include things like chemotherapy, hormone therapy, targeted therapy, and radiotherapy.

There are no specific reasons for someone to be excluded from this study if their records meet the above points. It’s important to remember that this study uses existing medical records and doesn’t involve any direct contact with patients or new treatments.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Did you have metastatic breast cancer?
Did you receive treatment for your first metastatic breast cancer since January 2008?
Was your treatment at one of the participating French cancer centres?

Answer every question to see your result.

What does participation involve?

If your medical records are part of this study, it means that information collected during your past treatment for metastatic breast cancer at a French cancer centre is being reviewed. You won't be asked to do anything new, such as having extra appointments, tests, or taking new medication. This study is entirely based on existing information. Your participation is completely passive, meaning that your medical records are being used anonymously by researchers to learn from, without you having to take any active steps or attend any follow-up visits specifically for this study. The total duration of this record review is ongoing as researchers continue to analyse the data.

Potential risks and benefits

There are no direct risks or benefits to individuals whose records are included in this study, as it only involves reviewing existing, anonymised medical information. You will not receive any new treatments or procedures. The potential benefit is for future patients, as the study aims to improve our understanding of metastatic breast cancer treatments over time, which could lead to better care for others. All data is handled with strict privacy, and individual details are anonymised. As this is a record review study, there is no direct personal involvement, so the concept of 'right to withdraw' in the traditional sense does not apply to individual patients, as your anonymised data is already part of a larger, aggregated dataset.

Locations (20)

Institut de Cancérologie de l'Ouest - Paul Papin
Verified postcode
Angers, France· Recruiting
Institut Bergonié
Verified postcode
Bordeaux, France· Recruiting
Centre François Baclesse
Verified postcode
Caen, France· Recruiting
Centre Jean Perrin
Verified postcode
Clermont-Ferrand, France· Recruiting
Centre Georges-François Leclerc
Verified postcode
Dijon, France· Recruiting
Centre Oscar Lambret
Verified postcode
Lille, France· Recruiting
Centre Léon Bérard
Verified postcode
Lyon, France· Recruiting
Institut Paoli-Calmettes
Verified postcode
Marseille, France· Recruiting
Institut régional du Cancer Montpellier / Val d'Aurelle
Verified postcode
Montpellier, France· Recruiting
Institut de Cancérologie de Lorraine
Verified postcode
Nancy, France· Recruiting
Institut de cancérologie de l'Ouest - René Gauducheau
Verified postcode
Nantes, France· Recruiting
Centre Antoine Lacassagne
Verified postcode
Nice, France· Recruiting

Common questions

What kind of information is being collected?

Researchers are looking at details like your age, the type of breast cancer you had, the treatments you received (like chemotherapy or hormone therapy), and how your cancer responded.

Will my name or personal details be used?

No, all information is made anonymous. Your personal details are protected, and the researchers cannot identify you from the data.

Do I need to do anything if my records are included?

No, you don't need to do anything. This study only uses existing historical medical records. You won't have extra appointments or treatments.

Why is this study being done?

The study aims to understand how metastatic breast cancer treatments have changed and improved since 2008, hoping to find better ways to care for future patients.

Will I get any results from this study?

Individual results are not provided since the study looks at large groups of anonymised data. However, the overall findings may be published to help the wider medical community.

How to find out more

Lise Bosquet, MsC

l-bosquet@unicancer.fr Official trial record

Always speak to your GP or specialist before deciding to take part in a study.